Use of marijuana, an antiemetic, is increasing among pregnant women, 1,2 and data from 2 small surveys 3,4 indicate that women self-report using marijuana to alleviate nausea and vomiting in pregnancy (NVP). To date, only 1 epidemiologic study 5 has examined whether women with NVP are at elevated risk of using marijuana. The study of 4735 pregnant women in Hawaii 5 from 2009 through 2011 found that selfreported prenatal marijuana use was more prevalent among those with (3.7%) vs without (2.3%) self-reported severe nausea during pregnancy. We used data from a large California health care system with standard universal screening for prenatal marijuana use via self-report and urine toxicologic tests from January .0, R11.10, R11.11, and R11.2]), or none. We estimated the adjusted odds of prenatal marijuana use among females with NVP using multilevel logistic regression, controlling for age, race/ ethnicity, median neighborhood household income, year, and self-reported marijuana use in the year before pregnancy from the universal screening questionnaire for prenatal substance use. We used in the PROC GLIMMIX procedure in SAS software (version 9.3; SAS Institute, Inc) for all analyses, and 2-sided P < .05 was considered statistically significant. Relative to females without NVP, those with severe (adjusted odds ratio, 3.80; 95% CI, 3.19-4.52; P < .001) and mild (adjusted odds ratio, 2.37; 95% CI, 2.17-2.59; P < .001) NVP had increased odds of marijuana use (Table) .
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Discussion | In a large, diverse sample of pregnant females from 2009 to 2016 who underwent universal marijuana screening in California, those with severe NVP had nearly 4 times greater odds of prenatal marijuana use, and those with mild NVP had more than 2 times greater odds of prenatal marijuana use than females without NVP. Although results are consistent with the hypothesis that women use marijuana to self-medicate for NVP, marijuana use may also contribute to NVP, or clinicians may diagnose NVP more frequently among women who report using marijuana to treat it.
This study was limited to pregnant females in KPNC who were screened for marijuana use at approximately 8 weeks gestation, and results may not generalize to females without health care coverage or with late entry to prenatal care. Clinicians may not diagnose very mild NVP, and our sample may reflect a subset of patients with more severe NVP. We could not distin-
